Sunshield Chemicals Limited has unveiled the terms of its upcoming rights issue, following approval from BSE Limited on September 12, 2025. The company aims to raise Rs. 129.90 crore through the issuance of fully paid-up equity shares, offering existing shareholders an opportunity to increase their stake in the company.

Rights Issue Details

Key Dates

Fractional and Zero Entitlements

Sunshield Chemicals has outlined specific provisions for fractional entitlements and shareholders with less than 6 shares:

1. Shareholders with less than 51 shares or holdings not in multiples of 51 will have fractional entitlements ignored in the Rights Entitlement computation.
2. These shareholders will receive preferential consideration for the allotment of one additional equity share if they apply for additional shares beyond their Rights Entitlement.
3. Shareholders holding less than 6 shares as of the Record Date will have zero entitlement but can apply for additional shares with preferential consideration for one additional share.

Additional Information

• The entire issue price of Rs. 901.00 per share is payable at the time of application.
• The Rights Issue Committee has the authority to extend the closing date, provided the issue period does not exceed 30 days from the opening date.
• The ISIN for dematerialized rights entitlement is INE199E20014.

Sunshield Chemicals Limited has stated that further details of the rights issue will be included in the Letter of Offer, which will be filed with the Securities and Exchange Board of India and BSE Limited.

This rights issue presents an opportunity for existing shareholders to increase their stake in Sunshield Chemicals Limited, while also allowing the company to raise significant capital for its operations and growth initiatives.

Sunshield Chemicals Limited has taken a significant step towards its planned rights issue, as announced in a recent corporate filing. The company's Rights Issue Committee convened on August 6, 2025, to approve the Draft Letter of Offer, marking a crucial milestone in the capital raising process.

Key Developments

• The Rights Issue Committee of Sunshield Chemicals' Board of Directors met on August 6, 2025.
• The committee approved the Draft Letter of Offer for the company's upcoming rights issue.
• The draft will be submitted to BSE Limited for in-principle approval.

Regulatory Compliance

Sunshield Chemicals Limited has promptly informed the stock exchange about this development, adhering to the compliance requirements set forth by the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015.

Company Details

What's Next

Investors and market participants will be watching for further developments in Sunshield Chemicals' rights issue process. The next crucial step will be obtaining in-principle approval from BSE Limited, which will pave the way for the company to proceed with its capital raising plans.

It's important to note that while the Draft Letter of Offer has been approved, the specifics of the rights issue, such as the issue size, pricing, and ratio, have not been disclosed in the current announcement. Shareholders and potential investors are advised to await further communications from the company for more details on the rights issue.

As this process unfolds, it could potentially impact the company's capital structure and provide existing shareholders with an opportunity to increase their stake in Sunshield Chemicals Limited.